Vytorin: ‘A Drug That Makes Us A Lot Of Money’

1 Comment

The Vytorin scandal is much more than a PR disaster for Merck and Schering-Plough, which spent more than $100 million last year to advertise the drug. The controversy is fanning the flames of public mistrust for the $5 billion direct-to-consumer drug industry - and the ad biz in general, Advertising Age writes. “The pharmas are in big trouble in terms of credibility,” marketing brand expert Rob Frankel tells the mag. “They’re just above Congress and used-car salesmen.”

Consider this parody of a Vytorin TV ad: The new tag line - “The cholesterol drug that redefines science to mean whatever we want.”

Jump to comments

Share

Comments

  1. Great video!

Subscribe

RSS Feed

Comments feed for this post only.

Tags

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/